Deciphering the role of LGALS2: insights into tertiary lymphoid structure-associated dendritic cell activation and immunotherapeutic potential in breast cancer patients.
Source check: Source checked. Not independent scientific confirmation.
Finding: Clustering and machine-learning analyses of large breast-cancer transcriptomic datasets identified TLS-associated subgroups and LGALS2; single-cell/spatial analyses report dendritic-cell associations, while survival associations remain observational. AI role: Network-based transcriptomic analysis and machine-learning methods. The article appeared in Molecular Cancer.
Technology: Network-based transcriptomic analysis and machine-learning methods
Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.
- AI contribution
- Network-based transcriptomic analysis and machine-learning methods
- Test and result
- Clustering and machine-learning analyses of large breast-cancer transcriptomic datasets identified TLS-associated subgroups and LGALS2; single-cell/spatial analyses report dendritic-cell associations, while survival associations remain observational.
- Limitation / still unknown
- The result is limited to the described dataset, cohort, experimental system, or validation design; generalization beyond that scope and downstream real-world benefit are not established. Author affiliation was not stated in the reviewed abstract or metadata.
Evidence sources and annotation context
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
Evidence sources: https://doi.org/10.1186/s12943-024-02126-4 · https://europepmc.org/article/MED/39350165 · https://europepmc.org/articles/PMC11441145 · https://www.ncbi.nlm.nih.gov/research/bionlp/RESTful/pmcoa.cgi/BioC_json/PMC11441145/unicode · https://pubmed.ncbi.nlm.nih.gov/39350165/
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.
Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..
No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.
Editorial assessment: Impact 2/5 · Validation 2/5 · Novelty 2/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.